Cargando…
Blood pressure lowering treatment and the Framingham score: Do not fear risk
Autores principales: | Brouwer, Tom F., Collard, Didier, van den Born, Bert‐Jan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973292/ https://www.ncbi.nlm.nih.gov/pubmed/31670866 http://dx.doi.org/10.1111/jch.13716 |
Ejemplares similares
-
Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population
por: Warner, Frederick, et al.
Publicado: (2018) -
Assessment of cardiovascular risk in Tunisia: applying the Framingham risk score to national survey data
por: Saidi, O, et al.
Publicado: (2016) -
Stage 1 hypertension defined by the 2017 ACC/AHA guideline predicts future cardiovascular events in elderly Chinese individuals
por: Xie, Yanxia, et al.
Publicado: (2019) -
Effect of Blood Pressure Variability on Outcomes in Emergency Patients with Intracranial Hemorrhage
por: Tran, Quincy K., et al.
Publicado: (2021) -
Application of the modified Framingham cardiovascular risk score to newly diagnosed type 2 black African diabetic patients
por: Kengne, Andre Pascal, et al.
Publicado: (2007)